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Abstract
DiGeorge syndrome is a primary immunodeficiency with microdeletion 22q11. Prenatal diagnosis
is possible. Typical disorders are heart defects of heart and large vessels, hypoplasia of the parathyroid
glands, dysmorphia, no thymus and immune deficiency.
The primary problem is the heart defect requiring cardiac surgical intervention. Due to the severi-
ty of the operation, immunodeficiency often goes into the background. Infections are associated with
cardiovascular abnormalities. The immune deficit is omitted without proper treatment including isola-
tion of the patient, substitution of i.v. immunoglobulin, chemo-prophylaxis. Blood products must be irra-
diated. What should be applied is oncology alertness and limitation of X-ray should also be noted. A com-
prehensive care reduces infections and improves the quality of life.
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aIntroduction
DiGeorge syndrome (often referred to as the 22q11.2
deletion syndrome) is one of well-defined primary immun-
odeficiency disorders associated with large defects [1]. The
syndrome was described for the first time in 1968 by Ange-
lo DiGeorge [2]. The literature still describes a similar coex-
istence of deficiencies, operating under the names:
• thymic hypoplasia with concomitant hypocalcemia,
• Takao syndrome (conotruncal anomaly face syndrome),
• velo-cardio-facial syndrome (VCFS, Shprintzen syn-
drome),
• Cayler cardiofacial syndrome,
• Opitz syndrome: genitourinary system irregularities in
addition to cleft palate, heart defects and mental retarda-
tion,
• CATCH-22 syndrome (an acronym formed from the first
letters of observed disorders: C – cardiac defects, A –
abnormal faces, T – thymic hypoplasia, H – hypocalcemia
from parathyroid aplasia, 22 – chromosome 22 microdele-
tions).
The syndrome affects 1 in 3000-5000 live births. 90%
of cases are 22q11.pter chromosome deletions (mostly
microdeletions) or 10p13 deletions (much less often) [3].
It is assumed that 72-90% of cases are a de novo genetic
defect. The remaining patients have an autosomal domi-
nant mutation inherited from the father or mother (three
times more), and therefore discrete features of dysmorphia
are observed in parents (they are asymptomatic carriers of
the 22q11.2 microdeletion) [4, 5]. The risk of the syndrome
in any subsequent child is 1 : 2 (50%).
The defect can be detected by fluorescence in situ
hybridization (FISH) that uses probes targeted only to a crit-
ical region [3, 6-8]. MLPA. Due to the high variability of
symptoms with the same kind of a genetic defect (loss of
genes in the 22q11.2 region), the medical image probably
also depends on a group of other genes, and therefore it can-
not be prenatally determined based on diagnosed microdele-
tions whose symptoms will occur. Therefore, due to a large
variability of the clinical picture, it is currently recom-
mended to use the term “22q11.2 microdeletion syndrome”.
The presence of characteristic mutations detected using the
FISH technique is not confirmed in approximately 10% of
patients diagnosed with the symptoms of the 22q11.2
microdeletion syndrome, because 10p13, 17p13 and
18q21.30 deletions or defects within individual genes are
also possible.
The symptoms of the syndrome relate to different sys-
tems and organs in the form of disorders (they can occur in
a variety of interrelations):
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• absence or dysfunction of the thymus and the associated
immune disorders,
• facial defects and abnormalities,
• cardiovascular abnormalities,
• metabolic and endocrine disorders,
• urological and nephrological abnormalities,
• neurological disorders.
In view of the wide variety of clinical pictures, criteria
of definitive, probable and possible diagnosis have been
developed to facilitate the diagnosis (Table 1) [8, 9].
Immune disorders
T lymphocytes are divided into subpopulations having
different functions and characterized by a specific pattern of
surface antigens. Differentiation of T cells occurs in the thy-
mus. Precursors of T lymphocytes from bone marrow pen-
etrate the cortical part of the thymus through the circulato-
ry path and differentiate into thymocytes (CD4+, CD8).
There is a positive selection of T cells in the cortex, but this
refers only to cells that recognize MHC antigens through
their TCR receptors. The others undergo apoptosis. Subse-
quently, the cells migrate into the cortical part of the thymus
where in the course of further maturation, with the use of
chemokines, the expression of surface antigens and antigen
receptors specific to T cells occurs. A negative selection in
turn takes place in the cortical part whereby cells highly reac-
tive to self-antigens are eliminated. The process of the neg-
ative selection results in a loss of approximately 90% of the
thymocyte population. At this stage, thymocytes eventual-
ly differentiate into cells that have only one of the antigens,
CD4 or CD8, and are exported to the periphery [10].
Very frequently no thymus shadow on chest X-ray films
is found in patients with the 22q11.2 microdeletion syn-
drome, which is of diagnostic importance and involves the
presence of abnormalities in cellular and/or humoral immu-
nity (deficit of T cells, especially CD4+, deficiency of major
classes of immunoglobulins, IgG subclasses and specific
antibodies) (Table 2). There are two forms of this syndrome:
complete with severe impairments of cellular response and
impaired humoral response, and partial in which the immune
response is slightly impaired, and spontaneous remission of
these irregularities is possible. A PHA-stimulated lympho-
cyte proliferation assay is useful in determining the form of
the syndrome [11]. The response to vaccination is most often
correct in the majority of patients diagnosed with impaired
synthesis of specific antibodies (in patients with incomplete
22q11.2 microdeletion syndrome) [12]. An increased inci-
dence of adverse vaccine reactions is not observed in this
group [13]. Immunization with live vaccines is contraindi-
cated in the case of low T-cell values or it should be post-
poned until the anomalies are resolved.
Data available in the literature show that 80% of
immune abnormalities observed in the neonatal period may
subside spontaneously in the first years of life [14]. It is now
believed that in children with congenital absence of thymus
or thymus removed during a cardiac surgery, the matura-
tion and differentiation of T lymphocytes still occur outside
the thymus, presumably from T lymphocytes present in the
gastrointestinal tract [15]. The immune system disorders
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Table 1. ESID criteria for diagnosing the microdeletion syndrome in the 22q11.2 chromosomal region [8, 9]
Definitive diagnosis Probable diagnosis Possible diagnosis
Heart or great vessels defect: Male or female child Male or female child
• patent ductus arteriosus
• tetralogy of Fallot
• interrupted aortic arch
• aberrant right subclavian artery
• Hypocalcaemia lasting Reduced number of CD3+ Reduced number of CD3 + T lymphocytes
more than 3 weeks, T lymphocytes (less than (less than 1500 per mm3)
requiring treatment 1500/mm3)
• Reduced number of CD3+
T lymphocytes (less than
500/mm)
Deletion of chromosome 22q11.2 Deletion of chromosome 22q11.2 One of the following disorders:
• heart defect
• hypocalcaemia lasting more than 3 weeks,
requiring treatment
• dysmorphic facial features or palatal anomalies
Definitive diagnosis of the Reduced number of CD3+ T lymphocytes (less than 50 per mm3) and all of the following:
complete DiGeorge syndrome • documented lack of thymus as less than 50 fresh thymic cells (CD3+ CD45RA+ CD62L+
cells/per mm3) and/or TRECs <100/100 000 T cells
• hypoparathyreosis
• heart defect
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result in recurrent infections of the respiratory and gas-
trointestinal tracts, most often of viral, fungal and proto-
zoan aetiology and less often of bacterial etiology.
The occurrence of immunodeficiency in the 22q11.2
microdeletion syndrome is also related to an increased risk
of autoimmune disease, as in other types of PID [16]. Juve-
nile idiopathic arthritis, Graves-Basedow disease are
observed [17, 18]. Thrombocytopenia and haemolytic
anaemia are also observed but the frequency is not known.
The cytopenias and other autoimmune diseases are more
prone due to altered T regulatory homeostasis [19].
Facial defects and abnormalities
Dysmorphic facial features are also characteristic of the
syndrome. They include an anti-mongoloid position of the
eyelids, widely spaced eyes, and the so-called fish mouth
caused by an underdeveloped lower jaw and short philtrum,
and small low-set ears.
Other abnormalities often relate to the palate and may
be the first symptoms of this syndrome. They can be man-
ifested by feeding difficulties – frequent regurgitation of
food, swallowing disorders. For this reason, children can
inadequately put on weight. These problems may be caused
by velopharyngeal insufficiency (the largest number of cas-
es) resulting from muscular hypotonia which can be direct-
ly accompanied by the submucosal cleft palate, open cleft
palate, cleft lip or tongue, which will greatly enhance the
observed abnormalities [20].
Cardiovascular abnormalities
Defects in the circulatory system are the most impor-
tant problem of patients with the 22q11.2 microdeletion syn-
drome. The severity of the defect and the possibility of car-
diac surgery directly affect the survival of children with this
syndrome [21]. The most common abnormalities include
a syndrome of defects known as tetralogy or pentalogy of
Fallot, common truncus arteriosus, transposition of the great
arteries. Other less common defects include narrowing of
the aortic orifice, pulmonary valve stenosis, right aortic arch
and syndromes which combine the specific defects. A heart
defect may not occur in about 26% of cases, and these are
the most common cases of unrecognized 22q11.2 microdele-
tion syndrome. As a result of an increased availability of
cardiac surgery centres and improved surgical techniques,
children with the most severe cardiovascular defects sur-
vive and require further multidisciplinary care.
Metabolic and endocrine disorders
Metabolic and endocrine disorders occur especially in
the form of hypocalcemia due to underdevelopment of the
parathyroid glands, which results in low levels of PTH
(parathyroid hormone). In extreme cases, these disorders
can cause tetany [22], or errors – diagnosis of epileptic
seizures. They are treated with calcium and vitamin D. The
symptoms are most common in the neonatal period, with
a tendency to disappear around 12-14 months of age. Symp-
toms of tetany, as a sign of increased demand for calcium,
may also occur in older children, especially in adolescence,
or in situations of stress, surgery, or in pregnant adults.
Urological and renal abnormalities
Abnormalities of the urinary tract may also occur in the
course of the syndrome [23]. Devriend et al. [24] report on
4 renal and urological malformations among 37 cases of
DiGeorge syndrome confirmed by genetic testing. Palacios
et al. [25] report on pathology within the kidneys and ureters
in as many as 7 of 11 patients with this syndrome.
Anomalies in the construction of kidneys and the uro-
genital tract (hypospadias) may cause nocturnal enuresis,
abnormal urination, or recurrent urinary tract infections, which
requires constant care or urological and renal correction [26].
Neurological and psychiatric disorders
Epilepsy or vertigo sometimes occurs in the syndrome.
At a later age concentration, learning, and abstract thinking
difficulties may take place [27]. There may also be adap-
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Table 2. Most common immunological abnormalities observed in 22q11.2 microdeletion syndrome patients [3, 11]
Microdeletion syndrome
complete partial
with severe immune disorders immune response is slightly impaired
Absolute number of CD3+ T cells significantly reduced in the group of the transient slight decrease
youngest patients
Quantitative abnormalities of CD4+ T cells high small
PHA blast transformation test impaired correct
Concentrations of IgG, IgA, IgM reduced (rarely) correct
Specific antibodies impaired synthesis impaired synthesis
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tive disorders in the peer group due to pronunciation diffi-
culties resulting from impaired speech organs. Serious men-
tal disorders such as schizophrenia, depression or bipolar
disorder are more often found in the population than in
healthy people [28]. The reasons are seen not only in the
chromosomal abnormalities, but also in chronic stress and
anxiety as a result of childhood experiences (surgery, expo-
sure to pain) [29].
Therapy in DiGeorge syndrome
Treatment of patients with DiGeorge syndrome has to
be comprehensive and multidisciplinary. There is a need for
life-saving cardiac surgery (heart defect), and surgery (cleft
palate, cleft lip), genetic counselling and genetic testing. In
some patients with the deep T lymphocyte deficit with con-
comitant severe infections and, in some patients with
a decrease in the immunoglobulins level, the use of
immunoglobulins either as a regular substitution or as an
adjuvant therapy in the course of infection, depending on
the clinical situation, is recommended. Immunization with
live vaccines is contraindicated in patients with a severe
immune deficiency (especially in terms of the number and
function of lymphocytes). Vaccinations can be implement-
ed in the incomplete 22q11.2 microdeletion syndrome as
no increased incidence of adverse vaccine reactions is
observed.
Microdeletion syndrome patients after cardiac surgery
still require multidisciplinary care. As in other primary
immunodeficiencies, there is an increased risk of develop-
ing tumours of the immune system cells in this syndrome.
These patients require the so-called oncological vigilance
and observation in the direction of autoimmune diseases,
but these diseases are less common. Children with this syn-
drome also require care in the field of the so-called early
intervention such as occupational therapy, rehabilitation
(physical and of speech disorders), educational and psy-
chological support.
The hematopoietic stem cells transplantation was sug-
gested in cases of DiGeorge syndrome but severe symptoms
of autoimmunity are the clinical indication. In these cases,
the stem cell transplantation is successful, which supports
the hypothesis that not the number of T lymphocytes but
the defect of the T cell function is responsible for clinical
symptoms in DiGeorge syndrome [5].
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